Ratings Shalby Limited Bombay S.E.

Equities

SHALBY

INE597J01018

Market Closed - Bombay S.E. Other stock markets 06:00:54 2024-07-12 am EDT			5-day change	1st Jan Change
287.7 ^INR	-2.95%		-7.49%	-4.72%

Jul. 09	Transcript : Shalby Limited, Q1 2025 Earnings Call, Jul 09, 2024
Jul. 09	Shalby's Consolidated Profit Drops in Fiscal Q1	MT

Strengths

The company's profit outlook over the next few years is a strong asset.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Weaknesses

The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 34.69 times its estimated earnings per share for the ongoing year.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

	1st Jan change	Capi.	ESG Refinitiv
SHALBY LIMITED	-4.72%	370M	-
AIER EYE HOSPITAL GROUP CO., LTD.	-31.86%	13.83B	B+
IHH HEALTHCARE	+4.98%	11.94B	B+
APOLLO HOSPITALS ENTERPRISE LIMITED	+11.39%	10.94B	B+
ENCOMPASS HEALTH CORPORATION	+29.71%	8.71B	B
THE ENSIGN GROUP, INC.	+19.71%	7.58B	B-
RAMSAY HEALTH CARE LIMITED	-9.73%	7.38B	A-
MOUWASAT MEDICAL SERVICES COMPANY	+7.33%	6.4B	D
FORTIS HEALTHCARE LIMITED	+14.60%	4.34B	B+
DALLAH HEALTHCARE COMPANY	-8.61%	4.09B	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes